mKRASvax
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for mKRASvax, covering 2025-12-03 to 2025-12-03. Get the full timeline:
Most recent: Clinical Trial Update: Comparing Neoadjuvant/Adjuvant GVAX vs a mKRASvax Given With Anti-PD-1 and Anti-CD137 for Surgically Resectable Pancreatic Cancer [Phase 1, Phase 2]